WO2012008765A3 - Composition pharmaceutique pour le traitement ou la prévention du cancer - Google Patents

Composition pharmaceutique pour le traitement ou la prévention du cancer Download PDF

Info

Publication number
WO2012008765A3
WO2012008765A3 PCT/KR2011/005170 KR2011005170W WO2012008765A3 WO 2012008765 A3 WO2012008765 A3 WO 2012008765A3 KR 2011005170 W KR2011005170 W KR 2011005170W WO 2012008765 A3 WO2012008765 A3 WO 2012008765A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
pharmaceutical composition
preventing cancer
compound
chemical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/005170
Other languages
English (en)
Korean (ko)
Other versions
WO2012008765A2 (fr
Inventor
이지훈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020110017286A external-priority patent/KR20120006923A/ko
Application filed by Individual filed Critical Individual
Priority to JP2013519594A priority Critical patent/JP2013530251A/ja
Publication of WO2012008765A2 publication Critical patent/WO2012008765A2/fr
Publication of WO2012008765A3 publication Critical patent/WO2012008765A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention porte sur le composé de formule chimique I, sur les sels pharmaceutiquement acceptables de celui-ci ou les hydrates de celui-ci, sur une composition pharmaceutique contenant le composé en tant que principe actif pour le traitement ou la prévention du cancer, et sur un procédé de préparation du composé de formule chimique I.
PCT/KR2011/005170 2010-07-13 2011-07-13 Composition pharmaceutique pour le traitement ou la prévention du cancer Ceased WO2012008765A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013519594A JP2013530251A (ja) 2010-07-13 2011-07-13 癌治療または予防用薬学組成物｛ｐｈａｒｍａｃｅｕｔｉｃａｌｃｏｍｐｏｓｉｔｉｏｎｆｏｒｔｒｅａｔｉｎｇｏｒｐｒｅｖｅｎｔｉｎｇｃａｎｃｅｒ｝

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR20100067614 2010-07-13
KR10-2010-0067614 2010-07-13
KR10-2011-0017286 2011-02-25
KR1020110017286A KR20120006923A (ko) 2010-07-13 2011-02-25 암 치료 또는 예방용 약학 조성물
KR10-2011-0069379 2011-07-13
KR1020110069379A KR101522712B1 (ko) 2010-07-13 2011-07-13 암 치료 또는 예방용 약학 조성물

Publications (2)

Publication Number Publication Date
WO2012008765A2 WO2012008765A2 (fr) 2012-01-19
WO2012008765A3 true WO2012008765A3 (fr) 2012-05-31

Family

ID=45469930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005170 Ceased WO2012008765A2 (fr) 2010-07-13 2011-07-13 Composition pharmaceutique pour le traitement ou la prévention du cancer

Country Status (1)

Country Link
WO (1) WO2012008765A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026015090A1 (fr) * 2024-07-11 2026-01-15 Emily (Thailand) Co., Ltd. Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167515A1 (en) * 2004-01-14 2007-07-19 Centre National De La Recherche Scientifique (Cnrs) Pyranone derivatives useful for treating cancer
KR20090085455A (ko) * 2008-02-04 2009-08-07 에스케이케미칼주식회사 항암활성을 갖는 5-아릴-2 파이론 유도체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167515A1 (en) * 2004-01-14 2007-07-19 Centre National De La Recherche Scientifique (Cnrs) Pyranone derivatives useful for treating cancer
KR20090085455A (ko) * 2008-02-04 2009-08-07 에스케이케미칼주식회사 항암활성을 갖는 5-아릴-2 파이론 유도체

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOEL, ATUL ET AL.: "A vicarious synthesis of unsymmetrical meta- and paraterphenyls from 2H-pyran-2-ones.", TETRAHEDRON LETTERS, vol. 46, 2005, pages 8487 - 8491 *
KASAPLAR, PINAR ET AL.: "6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties.", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 17, 2009, pages 311 - 318, XP025876000, DOI: doi:10.1016/j.bmc.2008.10.069 *
NARASIMHULU, MANCHALA ET AL.: "Stereoselective synthesis of (6S) and (6R)-5,6-dihydro-6- [(2R)-2-hydroxy-6-phenylhexyl]-2H-pyran-2-one and their cytotoxic activity against cancer cell lines.", TETRAHEDRON, vol. 65, 2009, pages 2989 - 2994, XP025970406, DOI: doi:10.1016/j.tet.2009.01.101 *

Also Published As

Publication number Publication date
WO2012008765A2 (fr) 2012-01-19

Similar Documents

Publication Publication Date Title
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
WO2010108074A3 (fr) Inhibiteurs de pi3 kinase
TN2012000248A1 (en) Novel spiropiperidine compounds
IN2014KN00948A (fr)
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
MY170935A (en) Neprilysin inhibitors
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
MX2013006802A (es) Inhibidores de neprilisina.
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
MD4602B1 (ro) Inhibitori ai virusului hepatic C
MY183312A (en) Pharmaceutical formulation
MX2016006667A (es) Derivados de pirrolo-pirrolona y su uso como inhibidores.
WO2013177534A3 (fr) Nouveaux dérivés d'acide salicylique, sel de qualité pharmaceutique correspondant, composition et procédé d'utilisation correspondants
WO2012135615A3 (fr) Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci
WO2012118308A3 (fr) Composition contenant un dérivé de pyrazole destinée à prévenir et à traiter les maladies cardiovasculaires
WO2014036502A8 (fr) Composés de tétracyclines
HK1209105A1 (en) Vegfr3 inhibitors
WO2012140596A8 (fr) Dérivés de glycoside et leurs utilisations
IN2012DN04868A (fr)
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
WO2012118309A3 (fr) Dérivés de pyrazole, procédé pour les préparer et composition les contenant destinée à prévenir et à traiter l'ostéoporose
HK1209104A1 (en) Vegfr3 inhibitors
WO2013062332A3 (fr) Composition anti-vieillissement vasculaire comprenant du syringarésinol
WO2012008765A3 (fr) Composition pharmaceutique pour le traitement ou la prévention du cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11807050

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2013519594

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 11807050

Country of ref document: EP

Kind code of ref document: A2